These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15352534)

  • 1. New approaches to the management and treatment of attention-deficit/hyperactivity disorder.
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S87-8. PubMed ID: 15352534
    [No Abstract]   [Full Text] [Related]  

  • 2. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention-deficit hyperactivity disorder diagnosis and treatment. Separating myth from substance.
    Barzman DH; Fieler L; Sallee FR
    J Leg Med; 2004 Mar; 25(1):23-38. PubMed ID: 15208788
    [No Abstract]   [Full Text] [Related]  

  • 4. Attention-deficit/hyperactivity disorder psychopharmacology for college students.
    Staufer WB; Greydanus DE
    Pediatr Clin North Am; 2005 Feb; 52(1):71-84, viii. PubMed ID: 15748925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder.
    Kollins SH; March JS
    Biol Psychiatry; 2007 Nov; 62(9):951-3. PubMed ID: 17950067
    [No Abstract]   [Full Text] [Related]  

  • 6. Attention-Deficit Hyperactivity Disorder.
    DuPont RL
    Essent Psychopharmacol; 2005; 6(5):iv. PubMed ID: 16222908
    [No Abstract]   [Full Text] [Related]  

  • 7. New options in the pharmacological management of attention-deficit/hyperactivity disorder.
    Olfson M
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S117-24. PubMed ID: 15352538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
    DelBello MP
    J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
    [No Abstract]   [Full Text] [Related]  

  • 9. Attention-deficit/hyperactivity disorder: focus on pharmacologic management.
    Reitz SJ
    J Pediatr Health Care; 1997; 11(2):78-83. PubMed ID: 9155352
    [No Abstract]   [Full Text] [Related]  

  • 10. Adolescent with history of hypercholesterolemia and ADHD: evidence-based practice.
    Muccino K
    J Pediatr Health Care; 2009; 23(4):263-8. PubMed ID: 19559994
    [No Abstract]   [Full Text] [Related]  

  • 11. Attention deficit/hyperactivity disorder: working the system for better diagnosis and treatment.
    Stevens S
    J Pediatr Nurs; 2005 Feb; 20(1):47-51. PubMed ID: 15834359
    [No Abstract]   [Full Text] [Related]  

  • 12. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulant utilization in treating attention-deficit/hyperactivity disorder in South Dakota's Medicaid population.
    Helgeland D
    S D Med; 2010 Nov; 63(11):383-4. PubMed ID: 21117519
    [No Abstract]   [Full Text] [Related]  

  • 14. Attention-deficit hyperactivity disorder. The psychostimulants and beyond.
    Ludwikowski K; DeValk M
    Adv Nurse Pract; 1998 Feb; 6(2):55-6, 59-60. PubMed ID: 9555283
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

  • 17. Addictive drugs still best option for attention deficit disorder.
    Basu P
    Nat Med; 2006 Apr; 12(4):374. PubMed ID: 16598272
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment with central nervous system stimulants].
    Zlotnik G
    Ugeskr Laeger; 2004 Mar; 166(10):925; author reply 925. PubMed ID: 15045741
    [No Abstract]   [Full Text] [Related]  

  • 19. Introduction: new developments in the treatment of attention-deficit/hyperactivity disorder.
    Biederman J
    J Clin Psychiatry; 2006; 67 Suppl 8():4-6. PubMed ID: 16961423
    [No Abstract]   [Full Text] [Related]  

  • 20. Innovations in attention-deficit/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments.
    Stein MA
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S89-98. PubMed ID: 15352535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.